Sandborn, William J <br/><br/>
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.  [electronic resource] 

 -  Gastroenterology  03 2019 
 - 946-957.e18 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2018.11.035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>C-Reactive Protein--metabolism<br/>CD4-Positive T-Lymphocytes--metabolism<br/>Colitis, Ulcerative--drug therapy<br/>Feces--chemistry<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Humans<br/>Integrins--antagonists & inhibitors<br/>Intestinal Mucosa<br/>Leukocyte L1 Antigen Complex--analysis<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Wound Healing--drug effects